Optiscan Imaging Stock

Optiscan Imaging Debt

The Debt of Optiscan Imaging (OIL.AX) as of Aug 22, 2026 is 1.48 M AUD. In the previous year, Debt was 220,900.00 AUD — a change of 570.44% (higher).

Debt

1.48 MAUD

YoY

570.44%

Last updated:

In 2026, Optiscan Imaging's total debt was 1.48 M AUD, a 570.44% change from the 220,900.00 AUD total debt recorded in the previous year.

The Optiscan Imaging Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
0.00 AUD
Jan 1, 2019
200,000.00 AUD
Jan 1, 2020
1.16 M AUD
Jan 1, 2021
668,000.00 AUD
Jan 1, 2022
548,700.00 AUD
Jan 1, 2023
412,300.00 AUD
Jan 1, 2024
220,900.00 AUD
Jan 1, 2025
1.48 M AUD
The Optiscan Imaging Debt history
YEARDebtYoY
1.48 MAUD+570.44%
220,900.00AUD-46.42%
412,300.00AUD-24.86%
548,700.00AUD-17.86%
668,000.00AUD-42.22%
1.16 MAUD+478.05%
200,000.00AUD—
0.00AUD—
0.00AUD-100.00%
1.12 MAUD+120.25%
510,500.00AUD+292.69%
130,000.00AUD—
Access this data via the Eulerpool API
Get Free API Key

Optiscan Imaging Stock analysis

What does Optiscan Imaging do? Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging is one of the most popular companies on Eulerpool.

Debt Details

Understanding Optiscan Imaging's Debt Structure

Optiscan Imaging's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Optiscan Imaging's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Optiscan Imaging’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Optiscan Imaging’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Optiscan Imaging stock

Debt of Optiscan Imaging is 1.48 M AUD in 2026.

Debt of Optiscan Imaging changed from 220,900.00 AUD to 1.48 M AUD, representing a 570.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Optiscan Imaging since 2006 – with annual values, charts, and detailed analysis.

Debt's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Optiscan Imaging historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Optiscan Imaging

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Optiscan Imaging